Subscribe to our Newsletters !!
The connection between genes and traits is one of
Our customers depend on the high performance and r
Few names in the medical history have had a profou
Alembic Pharmaceuticals Limited appoints Mr. Manis
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
The National Anti-Profiteering Authority (NAA) are questioning around 150 consumer goods and pharma companies regarding their stocks with the distributors and stockists on June 30,2017 were sold at low cost after the GST rollout.
These were some of the questions the NAA investigators are looking for answers. The NAA issues a letter to top leading pharma organization including Nirma, HUL, P&G, Lupin and Sun pharma in last two weeks.
They have many questions which has to be asked with them such as what happened to the stocks which were held by the consumers and pharma companies which was with the distributers and stockists on June 30, 2017? What were the changes in the prices and what price was charged to the customer when these products were sold?
Where as many companies announced the cut price after the GST rolled out which were applied to the new stocks or those manufactured after July 1, 2017.
